Richard Cheng is cardiology faculty at the University of Washington with a focus in cardiomyopathies, cardio-oncology and cardiac imaging. He is Program Director for the Heart Failure Fellowship and Director of the UW Cardio-oncology Program. He has extensive editorial experience, including serving on the editorial boards for JACC, JACC: Cardio-oncology, JHLT, and is an associate editor for Heart (BMJ). Additionally, he is topic editor for cardiomyopathies for ACC/HFSA HFSAPand an associate editor for ACC.orgfor heart failure and cardiomyopathies. His research focus over the last several years has been on risk stratification in heart failure and cardio-oncology cohorts. He has a particular interest in cause-specific cardiomyopathies including cancer therapy related cardiac dysfunction. Current roles include a study evaluating biomarkers after radiation therapy and association with subsequent long-term CVrisk, a cancer consortium grant studying exercise intervention in breast cancer survivors, serving as a cardiac events adjudicator for the RTOG-funded Radcomp study, being site-PI for UPBEAT, which is a longitudinal study of cardiotoxicity in women with breast cancer, developing an iPSC model to evaluate cardioprotection against chemotherapy-induced LV dysfunction, involvement with multiple studies with the Women’s Health Initiative evaluating HF risk in women, and collaborating on the Kaiser Pathways study, prospectively following breast cancer survivors for development of incident cardiovascular events.
Incoming Governor-Elect, Washington State ACC